EXPLORATORY STUDY OF PREDICTIVE BIOMARKER FOR DEFINITIVE CHEMORADIOTHERAPY USING BIOPSY SPECIMENS OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA.

(1) National Cancer Center Hospital East,Gastroenterology and Endoscopy,Kashiwa,Japan

(2) National Cancer Center Research,Translational Oncology,Chuo-ku,Japan

(3) National Cancer Center Hospital East,Gastroenterology and Oncology,kashiwa,Japan

(4) National Cancer Center Hospital East,Esophageal Surgery,Kashiwa,Japan

(5) Chiba Cancer Center,Clinical Trial Promotion,Chiba,Japan

(6) Kyoto University,Therapeutic Oncology,Kyoto,Japan

(7) National Cancer Center Hospital East,Pathology, Exploratory Oncology Research and Clinical Trial Center,Kashiwa,Japan



This item was part of UEG Week 2017

This item can be cited as: United European Gastroenterology Journal 2017; 5 (Supplement 1)